Click for best price
Postpemic Era Dysautonomia Treatment Drugs Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Post-pandemic Era-Global Dysautonomia Treatment Drugs Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate?, which aims to sort out the development status and trends of the Dysautonomia Treatment Drugs industry at home and abroad, estimate the overall market scale of the Dysautonomia Treatment Drugs industry and the market share of major countries, Dysautonomia Treatment Drugs industry, and study and judge the downstream market demand of Dysautonomia Treatment Drugs through systematic research, Analyze the competition pattern of Dysautonomia Treatment Drugs, so as to help solve the pain points of various stakeholders in Dysautonomia Treatment Drugs industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018- 2028) of Dysautonomia Treatment Drugs Market by Research Include
NorthAmerica
Asia
Europe
Middle East & Africa
South America
Competitive Analysis; Who are the Major Players in Dysautonomia Treatment Drugs Market?
Aspen Pharmacare
Bausch Health
Pfizer
AbbVie
Alpha Medical Manufacturers Limited
Boehringer Ingelheim
...
Major Type of Dysautonomia Treatment Drugs Covered in Research report:
Fludrocortisone
Midodrine
Beta-Blocker
Pyridostigmine
IV Saline
Others
Application Segments Covered in Research Market
Neurocardiogenic Syncope (NCS)
Postural Orthostatic Tachycardia Syndrome (POTS)
Familial Dysautonomia (FD)
Multiple System Atrophy (MSA)
Pure Autonomic Failure
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
Post-pandemic Era-Global Dysautonomia Treatment Drugs Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
83 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Post-pandemic Era-Global Dysautonomia Treatment Drugs Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Fludrocortisone -Product Introduction and Major Company
1.1.2 Midodrine -Product Introduction and Major Company
1.1.3 Beta-Blocker -Product Introduction and Major Company
1.1.4 Pyridostigmine -Product Introduction and Major Company
1.1.5 IV Saline -Product Introduction and Major Company
1.1.6 Others -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Dysautonomia Treatment Drugs Market Assessment by Type
3.1 Global Dysautonomia Treatment Drugs Sales by Type (2018-2028)
3.2 Global Dysautonomia Treatment Drugs Revenue by Type (2018-2028)
3.3 North America Dysautonomia Treatment Drugs Sales and Revenue by Type (2018-2028)
3.4 Asia Dysautonomia Treatment Drugs Sales and Revenue by Type (2018-2028)
3.5 Europe Dysautonomia Treatment Drugs Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Dysautonomia Treatment Drugs Sales and Revenue by Type (2018-2028)
3.7 South America Dysautonomia Treatment Drugs Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Dysautonomia Treatment Drugs Market Assessment by Application
4.1 Global Dysautonomia Treatment Drugs Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Dysautonomia Treatment Drugs Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Dysautonomia Treatment Drugs Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Dysautonomia Treatment Drugs Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Dysautonomia Treatment Drugs Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Dysautonomia Treatment Drugs Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
6.3 India Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
7.3 France Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Dysautonomia Treatment Drugs Sales, Revenue and Growth Rate (2018-2028)
10 Global Dysautonomia Treatment Drugs Average Price Trend
10.1 Market Price for Each Type of Dysautonomia Treatment Drugs in North America (2018-2028)
10.2 Market Price for Each Type of Dysautonomia Treatment Drugs in Asia (2018-2028)
10.3 Market Price for Each Type of Dysautonomia Treatment Drugs in Europe (2018-2028)
10.4 Market Price for Each Type of Dysautonomia Treatment Drugs in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Dysautonomia Treatment Drugs in South America (2018-2028)
11 Value Chain
11.1 Dysautonomia Treatment Drugs Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Dysautonomia Treatment Drugs Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Dysautonomia Treatment Drugs Market, Competitive Analysis
12.1 Aspen Pharmacare
12.1.1 Aspen Pharmacare Company Profiles and Company News
12.1.2 Aspen Pharmacare Product Introduction
12.1.3 Aspen Pharmacare Dysautonomia Treatment Drugs Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 Bausch Health
12.2.1 Bausch Health Company Profiles and Company News
12.2.2 Bausch Health Product Introduction
12.2.3 Bausch Health Dysautonomia Treatment Drugs Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Pfizer
12.3.1 Pfizer Company Profiles and Company News
12.3.2 Pfizer Product Introduction
12.3.3 Pfizer Dysautonomia Treatment Drugs Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 AbbVie
12.4.1 AbbVie Company Profiles and Company News
12.4.2 AbbVie Product Introduction
12.4.3 AbbVie Dysautonomia Treatment Drugs Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5.1 Alpha Medical Manufacturers Limited Company Profiles and Company News
12.5.2 Alpha Medical Manufacturers Limited Product Introduction
12.5.3 Alpha Medical Manufacturers Limited Dysautonomia Treatment Drugs Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Profiles and Company News
12.6.2 Boehringer Ingelheim Product Introduction
12.6.3 Boehringer Ingelheim Dysautonomia Treatment Drugs Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
13 Global Dysautonomia Treatment Drugs Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Dysautonomia Treatment Drugs Market
13.2 Concentration Ratio (CR5) of Global Dysautonomia Treatment Drugs Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Dysautonomia Treatment Drugs Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure Product Introduction
Table Sales (K Units) and Revenue (Million USD) of Major Players (2018-2022)
Figure Global Dysautonomia Treatment Drugs Sales Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Sales of Each Type (2018-2028)
Table Regional Market Share in Terms of Sales (2019-2026)
Figure Regional Market Share in Terms of Sales (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Dysautonomia Treatment Drugs Sales (K Unit) by Type (2018-2028)
Figure Global Dysautonomia Treatment Drugs Sales (K Unit) and Growth Rate (2018-2028)
Figure Global Dysautonomia Treatment Drugs Sales Market Share (%) by Type (2019 -2020)
Table Global Dysautonomia Treatment Drugs Revenue (Million USD) by Type (2018-2028)
Figure Global Dysautonomia Treatment Drugs Revenue (Million USD) and Growth Rate (2018-2028)
Figure Global Dysautonomia Treatment Drugs Revenue Market Share (%) by Type (2019-2020)
Figure North America Dysautonomia Treatment Drugs Sales (K Unit) by Type (2018-2028)
Figure North America Dysautonomia Treatment Drugs Sales (K Unit) and Growth Rate (2018-2028)
Figure North America Dysautonomia Treatment Drugs Revenue (Million USD) by Type (2018-2028)
Figure North America Dysautonomia Treatment Drugs Revenue (Million USD) and Growth Rate (2018-2028)
Figure Asia Dysautonomia Treatment Drugs Sales (K Unit) by Type (2018-2028)
Figure Asia Dysautonomia Treatment Drugs Sales (K Unit) and Growth Rate (2018-2028)
Figure Asia Dysautonomia Treatment Drugs Revenue (Million USD) by Type (2018-2028)
Figure Asia Dysautonomia Treatment Drugs Revenue (Million USD) and Growth Rate (2018-2028)
Figure Europe Dysautonomia Treatment Drugs Sales (K Unit) by Type (2018-2028)
Figure Europe Dysautonomia Treatment Drugs Sales (K Unit) and Growth Rate (2018-2028)
Figure Europe Dysautonomia Treatment Drugs Revenue (Million USD) by Type (2018-2028)
Figure Europe Dysautonomia Treatment Drugs Revenue (Million USD) and Growth Rate (2018-2028)
Figure Middle East & Africa Dysautonomia Treatment Drugs Sales (K Unit) by Type (2018-2028)
Figure Middle East & Africa Dysautonomia Treatment Drugs Sales (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Dysautonomia Treatment Drugs Revenue (Million USD) by Type (2018-2028)
Figure Middle East & Africa Dysautonomia Treatment Drugs Revenue (Million USD) and Growth Rate (2018-2028)
Figure South America Dysautonomia Treatment Drugs Sales (K Unit) by Type (2018-2028)
Figure South America Dysautonomia Treatment Drugs Sales (K Unit) and Growth Rate (2018-2028)
Figure South America Dysautonomia Treatment Drugs Revenue (Million USD) by Type (2018-2028)
Figure South America Dysautonomia Treatment Drugs Revenue (Million USD) and Growth Rate (2018-2028)
Table Historical & Forecast Dysautonomia Treatment Drugs Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2018-2028)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Dysautonomia Treatment Drugs Different Application Field Consumption (K Unit)
Figure North America Dysautonomia Treatment Drugs Consumption (K Unit) and Growth Rate (2018-2028)
Figure North America Dysautonomia Treatment Drugs Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Dysautonomia Treatment Drugs Different Application Field Consumption (K Unit)
Figure Asia Dysautonomia Treatment Drugs Consumption (K Unit) and Growth Rate (2018-2028)
Figure Asia Dysautonomia Treatment Drugs Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Dysautonomia Treatment Drugs Different Application Field Consumption (K Unit)
Figure Europe Dysautonomia Treatment Drugs Consumption (K Unit) and Growth Rate (2018-2028)
Figure Europe Dysautonomia Treatment Drugs Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Dysautonomia Treatment Drugs Different Application Field Consumption (K Unit)
Figure Middle East & Africa Dysautonomia Treatment Drugs Consumption (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Dysautonomia Treatment Drugs Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Dysautonomia Treatment Drugs Different Application Field Consumption (K Unit)
Figure South America Dysautonomia Treatment Drugs Consumption (K Unit) and Growth Rate (2018-2028)
Figure South America Dysautonomia Treatment Drugs Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Dysautonomia Treatment Drugs Different Application Field Consumption (K Unit)
Table US Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Dysautonomia Treatment Drugs Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Dysautonomia Treatment Drugs in China
Table Market Price (USD/Unit) for Each Type of Dysautonomia Treatment Drugs in EU
Table Market Price (USD/Unit) for Each Type of Dysautonomia Treatment Drugs in USA
Table Market Price (USD/Unit) for Each Type of Dysautonomia Treatment Drugs in Japan
Table Market Price (USD/Unit) for Each Type of Dysautonomia Treatment Drugs in India
Table Market Price (USD/Unit) for Each Type of Dysautonomia Treatment Drugs in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Dysautonomia Treatment Drugs in South America
Figure Value Chain Structure of Dysautonomia Treatment Drugs
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Dysautonomia Treatment Drugs
Figure Cost Structure of Dysautonomia Treatment Drugs in 2020
Table Distributors/Traders List
Table Aspen Pharmacare Profiles
Table Aspen Pharmacare Dysautonomia Treatment Drugs Product Introduction
Figure Aspen Pharmacare Dysautonomia Treatment Drugs Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Aspen Pharmacare SWOT Analysis
Table Bausch Health Profiles
Table Bausch Health Dysautonomia Treatment Drugs Product Introduction
Figure Bausch Health Dysautonomia Treatment Drugs Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Bausch Health SWOT Analysis
Table Pfizer Profiles
Table Pfizer Dysautonomia Treatment Drugs Product Introduction
Figure Pfizer Dysautonomia Treatment Drugs Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Pfizer SWOT Analysis
Table AbbVie Profiles
Table AbbVie Dysautonomia Treatment Drugs Product Introduction
Figure AbbVie Dysautonomia Treatment Drugs Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure AbbVie SWOT Analysis
Table Alpha Medical Manufacturers Limited Profiles
Table Alpha Medical Manufacturers Limited Dysautonomia Treatment Drugs Product Introduction
Figure Alpha Medical Manufacturers Limited Medical Devices & Consumables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Alpha Medical Manufacturers Limited SWOT Analysis
Table Boehringer Ingelheim Profiles
Table Boehringer Ingelheim Dysautonomia Treatment Drugs Product Introduction
Figure Boehringer Ingelheim Dysautonomia Treatment Drugs Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Boehringer Ingelheim SWOT Analysis
